Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Evaluation of proteomic biomarkers associated with circulating microparticles as an effective means to stratify the risk of spontaneous preterm birth.

Cantonwine DE, Zhang Z, Rosenblatt K, Goudy KS, Doss RC, Ezrin AM, Page G, Brohman B, McElrath TF.

Am J Obstet Gynecol. 2016 May;214(5):631.e1-631.e11. doi: 10.1016/j.ajog.2016.02.005. Epub 2016 Feb 11.

2.

Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs.

Akbarpour M, Goudy KS, Cantore A, Russo F, Sanvito F, Naldini L, Annoni A, Roncarolo MG.

Sci Transl Med. 2015 May 27;7(289):289ra81. doi: 10.1126/scitranslmed.aaa3032.

PMID:
26019217
3.

The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.

Gregori S, Goudy KS, Roncarolo MG.

Front Immunol. 2012 Feb 29;3:30. doi: 10.3389/fimmu.2012.00030. eCollection 2012.

4.

Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy.

Goudy KS, Annoni A, Naldini L, Roncarolo MG.

Front Microbiol. 2011 Nov 14;2:221. doi: 10.3389/fmicb.2011.00221. eCollection 2011.

5.

Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.

Goudy KS, Johnson MC, Garland A, Li C, Samulski RJ, Wang B, Tisch R.

Eur J Immunol. 2011 May;41(5):1480-1490. doi: 10.1002/eji.201040890. Epub 2011 Apr 20.

6.

Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.

Goudy KS, Johnson MC, Garland A, Li C, Samulski RJ, Wang B, Tisch R.

J Immunol. 2011 Mar 15;186(6):3779-86. doi: 10.4049/jimmunol.1001422. Epub 2011 Feb 11.

7.
8.

The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.

9.

Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets.

Wong CP, Stevens R, Long B, Li L, Wang Y, Wallet MA, Goudy KS, Frelinger JA, Tisch R.

J Immunol. 2007 Feb 1;178(3):1388-95.

10.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
11.

Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells.

Burkhardt BR, Loiler SA, Anderson JA, Kilberg MS, Crawford JM, Flotte TR, Goudy KS, Ellis TM, Atkinson M.

Ann N Y Acad Sci. 2003 Nov;1005:237-41.

PMID:
14679068
12.

Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.

Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA.

J Immunol. 2003 Sep 1;171(5):2270-8.

Supplemental Content

Loading ...
Support Center